Treats psoriasis of the scalp (Scalp Oil). ANDA 90982, held by Rising. Fluocinolone Acetonide.
As of Nov 16, 2026, ANDA 90982 (Fluocinolone Acetonide), held by Rising, was first approved by FDA on Apr 25, 2016, with 1 approved supplement and 0 published complete response letters.
INDICATION AND USAGE Fluocinolone acetonide topical oil, 0.01% is a low to medium potency corticosteroid indicated: In adult patients for the treatment of psoriasis of the scalp (Scalp Oil).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 25, 2016 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluocinolone Acetonide0.01% · oil;topical | Fluocinolone Acetonide | Rx |
| Sep 16, 2025 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 25, 2016 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters